Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02420665 · ClinicalTrials.gov registry record · Early Phase 1
Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia
A Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 50
- Enrollment target
NCT02420665: Completed Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT02420665 is a Early Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02420665, a Early Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to compare a type of imaging called high-resolution microendoscopy (HRME) for detecting abnormal tissue in the cervix to the standard of care, which is visual inspection with acetic acid (VIA) with a colposcopy procedure. Researchers also want to learn if HRME images can show the difference between cancerous tissue and normal cervical tissue.
Interventions
- PROCEDURE Colposcopy
- DRUG Proflavine
- BEHAVIORAL Phone Call
- DEVICE HRME Imaging
- DRUG Acetic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-09-23 |
| Est. Completion | 2021-05-14 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02420665
The ClinicalTrials.gov registry entry for NCT02420665 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Colposcopy is the first listed.
NCT02420665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02420665 about?
NCT02420665 is a clinical study titled "Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia". The goal of this clinical research study is to compare a type of imaging called high-resolution microendoscopy (HRME) for detecting abnormal tissue in the cervix to the standard of care, which is visual inspection with acetic acid (VIA) with a colposcopy procedure. Researchers also want to learn if ...
What is the current status of trial NCT02420665?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2015-09-23. Estimated completion is 2021-05-14.
What interventions are being tested in trial NCT02420665?
The interventions under investigation include: Colposcopy (PROCEDURE), Proflavine (DRUG), Phone Call (BEHAVIORAL), HRME Imaging (DEVICE), Acetic Acid (DRUG).
Who is sponsoring clinical trial NCT02420665?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.